Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Julian Taugner"'
Autor:
Lukas Käsmann, Chukwuka Eze, Julian Taugner, Olarn Roengvoraphoj, Maurice Dantes, Nina-Sophie Schmidt-Hegemann, Sanziana Schiopu, Claus Belka, Farkhad Manapov
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-14 (2020)
Abstract Immune-checkpoint inhibitors (ICI) have dramatically changed the landscape of lung cancer treatment. Preclinical studies investigating combination of ICI with radiation show a synergistic improvement of tumor control probability and have res
Externí odkaz:
https://doaj.org/article/4e9000d77273443982ebf27f139fecaf
Autor:
Julian Taugner, Chukwuka Eze, Lukas Käsmann, Olarn Roengvoraphoj, Kathrin Gennen, Monika Karin, Oleg Petrukhnov, Amanda Tufman, Claus Belka, Farkhad Manapov
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-9 (2020)
Abstract Background Loco-regional and distant failure are common in inoperable stage III non small-cell lung cancer (NSCLC) after chemoradiotherapy (CRT). However, there is limited real-world data on failure pattern, patient prognosis and salvage opt
Externí odkaz:
https://doaj.org/article/a344673347554281b6d472de0edb625a
Autor:
Kathrin Gennen, Lukas Käsmann, Julian Taugner, Chukwuka Eze, Monika Karin, Olarn Roengvoraphoj, Jens Neumann, Amanda Tufman, Michael Orth, Simone Reu, Claus Belka, Farkhad Manapov
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-12 (2020)
Abstract Background/aim mmune checkpoint inhibition (CPI) has an increasing impact in the multimodal treatment of locally advanced non-small cell lung cancer (LA-NSCLC). Increasing evidence suggests treatment outcome depending on tumor cell PD-L1 exp
Externí odkaz:
https://doaj.org/article/2bbd9933800948f78581ecc46477f86f
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-3 (2020)
Abstract We read the article entitled “Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer” with great interest. In that study, the auth
Externí odkaz:
https://doaj.org/article/fd17b2c29620428ab5904772179a36cc
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 19, p 5713 (2022)
Thoracic radiotherapy (TRT) plays an integral role in the multimodal treatment of lung cancer, breast cancer, esophageal cancer, thymoma and mesothelioma, having been used as either a definitive, neoadjuvant or adjuvant treatment or for palliative in
Externí odkaz:
https://doaj.org/article/9108f9f1f9ee473fae6a6e785464b2dd
Autor:
Chukwuka Eze, Julian Taugner, Olarn Roengvoraphoj, Nina-Sophie Schmidt-Hegemann, Lukas Käsmann, Cherylina Wijaya, Claus Belka, Farkhad Manapov
Publikováno v:
Radiation Oncology, Vol 14, Iss 1, Pp 1-7 (2019)
Abstract Background To determine the feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation (Hypo-IGRT) in locally advanced node-positive non-small cell lung cancer patients with highly compromised pulmonary function.
Externí odkaz:
https://doaj.org/article/12fd2b7fbe3f4d8ab800d42db2695504
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/f3d8fb19ae8c474fad67e6b6811d9c14
Autor:
Diego Kauffmann-Guerrero, Julian Taugner, Chukwuka Eze, Lukas Käsmann, Minglun Li, Amanda Tufman, Farkhad Manapov
Publikováno v:
Diagnostics, Vol 11, Iss 11, p 1968 (2021)
Background: Maintenance treatment with immune-checkpoint inhibition (ICI) has been shown to significantly improve patient prognosis after chemoradiotherapy (CRT) for inoperable stage III NSCLC. This survival advantage may be achieved at the expense o
Externí odkaz:
https://doaj.org/article/ef9e50f837684b1da1f03b372574e648
Autor:
Julian Taugner, Lukas Käsmann, Chukwuka Eze, Amanda Tufman, Niels Reinmuth, Thomas Duell, Claus Belka, Farkhad Manapov
Publikováno v:
Cancers, Vol 13, Iss 7, p 1613 (2021)
Concurrent chemoradiotherapy (CRT) followed by maintenance treatment with the PD-L1 inhibitor durvalumab is a new standard of care for inoperable stage III NSCLC. The present study compares the oncological outcome of patients treated with CRT to thos
Externí odkaz:
https://doaj.org/article/07ed8c0d632a45d18f2b4ec335e633f0
Autor:
Monika Karin, Julian Taugner, Lukas Käsmann, Chukwuka Eze, Olarn Roengvoraphoj, Amanda Tufman, Claus Belka, Farkhad Manapov
Publikováno v:
Cancers, Vol 12, Iss 10, p 3035 (2020)
Inoperable stage III non-small cell lung cancer (NSCLC) represents a highly heterogeneous patient cohort. Multimodal treatment approaches including radiotherapy have been the new standard of care, with promising outcomes. The planning target volume (
Externí odkaz:
https://doaj.org/article/4cd66a6570534f04a89991b62efffb32